The role of nailfold videocapillaroscopy in raynaud's phenomenon monitoring and early diagnosis of systemic sclerosis;La videocapillaroscopia ungueale nel monitoraggio del fenomeno di raynaud e nella diagnosi precoce della sclerosi sistemica

Reumatismo

Volumn 62, Issue 4, 2010, Pages 237-247

  Cutolo, Maurizio ^a   Pizzorni, C ^a   Meroni, M ^a   Zampogna, G ^a   Ferrone, C ^a   Alessandri, E ^a   Ravera, F ^a   Sulli, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Microvascular damage; Monitoring.; Nailfold videocapillaroscopy; Raynaud phenomenon; Systemic sclerosis

Indexed keywords

CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC TEST; EARLY DIAGNOSIS; HUMAN; NAILFOLD VIDEOCAPILLAROSCOPY; PREDICTION; RAYNAUD PHENOMENON; RELIABILITY; REVIEW; SAFETY; SYSTEMIC SCLEROSIS; VASOSPASM;

EARLY DIAGNOSIS; HUMANS; MICROSCOPIC ANGIOSCOPY; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; VIDEO RECORDING;

EID: 79251509270     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Allen EV, Brown GE. Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med Sci 1932: 183: 187-200.
2. Nihtyanova SI, Brough GM, Black CM, Denton CP. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 2008; 67: 120-3.
3. Cutolo M, Grassi W, Matucci Cerinic M. Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 2003; 48: 3023-30.
4. Block JA, Sequeira W. Raynaud's phenomenon. Lancet 2001; 357: 2042-8.
5. Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford) 2005; 44: 587-96.
6. LeRoy EC, Medsger TA. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992; 10: 485-8.
7. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
8. Matucci-Cerinic M, Allanore Y, Czirják L, Tyndall A, Müller-Ladner U, Denton C, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research Group (EUSTAR) community, It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009; 68: 1377-80.
9. Spencer-Green G. Outcomes in primary Raynaud phenomenon. A meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med 1998; 158: 595-600.
10. Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hut-ter H-P, Kundi M. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease. Arthritis Rheum 2006; 54: 1974-81.
11. Bukhari M, Herrick AL, Moore T, Manning J, Jayson MIV. Increased nailfold capillary dimensions in primary Raynaud's phenomenon and systemic sclerosis. Br J Rheumatol 1996; 35: 1127-31.
12. Chrysant SG. Vascular remodeling: the role of an-giotensin-converting enzyme inhibitors. Am Heart J 1998; 135: S21-30.
13. Fishman AP. Pulmonary hypertension - beyond vasodilator therapy. N Eng J Med 1998; 338: 321-2.
14. Kirchengast M, Munter K. Endothelin-1 and endothe-lin receptor antagonists in cardiovascular remodeling. PSEBM 1999; 221: 312-25.
15. Aschwanden M, Daikeler T, Jaeger KA, Thalhammer C, Gratwohl A, Matucci-Cerinic M, et al. Rapid improvement of nailfold capillaroscopy after intense immuno-suppression for systemic sclerosis and mixed connective tissue disease. Ann Rheum Dis 2008; 67: 1057-9.
16. Miniati I, Guiducci S, Conforti ML, Rogai V, Fiori G, Cinelli M, et al. Autologous stem cell transplantation improves microcirculation in systemic sclerosis. Ann Rheum Dis 2009; 68: 94-8.
17. Hudson M, Thombs B, Baron M. Time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum (Arthritis Care Res) 2009; 61: 274-8.
18. Maricq HR, LeRoy EC. Patterns of finger capillary abnormalities in connective tissue disease by "wide-field" microscopy. Arthritis Rheum 1973; 16: 619-28.
19. Cutolo M, Pizzorni C, Secchi ME, Sulli A. Capil-laroscopy. Best Pract Res Clin Rheumatol 2008; 22: 1093-108.
20. Carpentier P, Franco A, Béani JC, Reymond JL, Am-blard P. Value of periungual capillaroscopy in the early diagnosis of systemic scleroderma. Ann Dermatol Venereol 1983; 110: 11-20.
21. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155-60.
22. De Angelis R, Grassi W, Cutolo M. A growing need for capillaroscopy in rheumatology. Arthritis Rheum 2009; 61: 405-10.
23. Grassi W, Medico PD, Izzo F, Cervini C. Microvascu-lar involvement in systemic sclerosis: capillaroscopic findings. Semin Arthritis Rheum 2001; 30: 397-402.
24. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155-60.
25. Sulli A, Secchi ME, Pizzorni C, Cutolo M. Scoring the nailfold microvascular changes during the capillaro-scopic analysis in systemic sclerosis patients. Ann Rheum Dis 2008; 67: 885-7.
26. Smith V, Pizzorni C, De Keyser F, Decuman S, Van Praet J, Deschepper E, et al. Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a bi-centre study. Ann Rheum Dis 2010; 69: 1092-6.
27. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abra-hamowicz M, Boire G, et al. Autoantibodies and mi-crovascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008; 58: 3902-12.
28. Cutolo M, Pizzorni C, Sulli A. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapil-laroscopy. Arthritis Rheum 2007; 56: 2102-3.
29. Valim V, Assis LS, Simões MF, Trevisani VF, Pucinel-li ML, Andrade LE. Correlation between serum E-se-lectin levels and panoramic nailfold capillaroscopy in systemic sclerosis. Braz J Med Biol Res 2004; 37: 1423-7.
30. Del Rosso A, Distler O, Milia AF, Emanueli C, Ibba-Manneschi L, Guiducci S, et al. Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement. Ann Rheum Dis 2005; 64: 382-7.
31. Sulli A, Soldano S, Pizzorni C, Montagna P, Secchi ME, Villaggio B, et al. Raynaud's phenomenon and plasma endothelin: Correlations with capillaroscopic patterns in systemic sclerosis. J Rheumatol 2009; 36: 1235-9.
32. Soldano S, Montagna P, Villaggio B, Parodi A, Gian-otti G, Sulli A, et al. Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts. Ann Rheum Dis 2009; 68: 599-602.
33. Volpe A, Biasi D, Caramaschi P, Mantovani W, Bam-bara LM, Canestrini S, et al. Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features. Rheumatology (Oxford) 2006; 45: 314-20.
34. Riccieri V, Germano V, Alessandri C, Vasile M, Cec-carelli F, Sciarra I, et al. More severe nailfold capil-laroscopy findings and anti-endothelial cell antibodies. Are they useful tools for prognostic use in systemic sclerosis? Clin Exp Rheumatol 2008; 26: 992-7.
35. Cutolo M, Pizzorni C, Tuccio M, Burroni A, Craviot-to C, Basso M, et al. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 719-26.
36. Caramaschi P, Canestrini S, Martinelli N, Volpe A, Pieropan S, Ferrari M, et al. Scleroderma patients nail-fold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatology (Oxford) 2007; 46: 1566-9.
37. Smith V, Pizzorni C, De Keyser F, Decuman S, Van Praet J, Deschepper E, et al. Validation of the qualitative and semiquantitative assessment of the scleroderma spectrum patterns by nailfold videocapillaroscopy: preliminary results. Arthritis Rheum 2009; 60: S164-S5.
38. Beyer C, Schett G, Gay S, Distler O, Distler JH. Hypoxia in the pathogenesis of systemic sclerosis. Arthritis Res Ther 2009; 11: 220-7.
39. Alivernini S, De Santis M, Tolusso B, Mannocci A, Bosello SL, Peluso G, et al. Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing. J Am Acad Dermatol 2009; 60: 426-35.
40. Sebastiani M, Manfredi A, Colaci M, D'amico R, Malagoli V, Giuggioli D, et al. Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009; 61: 688-94.
41. Mugii N, Hasegawa M, Hamaguchi Y, Tanaka C, Ka-ji K, Komura K, et al. Reduced red blood cell velocity in nail-fold capillaries as a sensitive and specific indicator of microcirculation injury in systemic sclerosis. Rheumatology (Oxford) 2009; 48: 696-703.
42. Ong YY, Nikoloutsopoulos T, Bond CP, Smith MD, Ahern MJ, Roberts-Thomson PJ. Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension. Asian Pac J Allergy Immunol 1998; 16: 81-6.
43. Bredemeier M, Xavier RM, Capobianco KG, Restelli VG, Rohde LE, Pinotti AF, et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004; 31: 286-94.
44. Hofstee HM, Noordegraaf AV, Voskuyl AE, Dijkmans BA, Postmus PE, Smulders YM, et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis 2009; 68: 191-5.
45. Anderson ME, Allen PD, Moore T, Hillier V, Taylor CJ, Herrick AL. Computerised nailfold video capil-laroscopy - a new tool for the assessment of Raynaud's phenomenon. J Rheumatol 2005; 32: 841-8.
46. Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA, et al. Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 1994: 120: 199-206.
47. Pope J, Fenlon D, Thompson A, Shea B, Furst D, Wells G, et al. Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis (Cochrane Review). In: The Cochrane Library, Issue 3, 2002. Oxford: Update Software.
48. Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, et al. For the RAPIDS-1 Study Group. Digital ulcers in systemic sclerosis. Prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004; 50: 3985-93.
49. Gliddon AE, Doré CJ, Black CM, McHugh N, Moots R, Denton CP, et al. Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a randomised controlled trial of the ACE-inhibitor quinapril. Arthritis Rheum 2007; 56: 3837-46.
50. Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, et al. MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon. Arthritis Rheum 2009; 60: 870-7.
51. Moore TL, Vail A, Herrick AL. Assessment of digital vascular structure and function in response to bosentan in patients with systemic sclerosis-related Raynaud's phenomenon. Rheumatology (Oxford) 2007; 46: 363-4.
52. Anders HJ, Sigl T, Schattenkirchner M. Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capil-laroscopy using an opthalmoscope or stereomicroscope. Ann Rheum Dis 2001; 60: 407-9.
53. Bergman R, Sharony L, Shapira D, Nahir MA, Balbir-Gurman A. The handheld dermatoscope as a nail-fold capillaroscopic instrument. Arch Dermatol 2003; 139: 1027-30.
54. Baron M, Bell M, Bookman A, Buchignani M, Dunne J, Hudson M, et al. Office capillaroscopy in systemic sclerosis. Clin Rheumatol 2007; 26: 1268-74.
55. Moore TL, Roberts C, Murray AK, Helbling I, Herrick AL. Reliability of dermoscopy in the assessment of patients with Raynaud's phenomenon. Rheumatology (Oxford) 2010; 49: 542-7.
56. De Angelis R, Cutolo M, Salaffi F, Restrepo JP, Grassi W. Quantitative and qualitative assessment of one rheumatology trainee's experience with a self-teaching programme in videocapillaroscopy. Clin Exp Rheuma-tol 2009; 27: 651-3.